Infringement Finding Affirmed By Federal Circuit In Antibiotic Injection Dispute
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on June 5 affirmed an Illinois federal judge’s finding that an appellant biopharmaceutical company’s generic version of an injectable antibiotic...To view the full article, register now.
Already a subscriber? Click here to view full article